FibroGen Inc (FGEN)
1.14
+0.01
(+0.88%)
USD |
NASDAQ |
May 03, 16:00
1.125
-0.02
(-1.32%)
After-Hours: 20:00
FibroGen Gross Profit (TTM): 128.90M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 128.90M |
September 30, 2023 | 136.61M |
June 30, 2023 | 112.15M |
March 31, 2023 | 96.54M |
December 31, 2022 | 120.46M |
September 30, 2022 | 104.43M |
June 30, 2022 | 245.71M |
March 31, 2022 | 244.00M |
December 31, 2021 | 222.44M |
September 30, 2021 | 271.40M |
Date | Value |
---|---|
June 30, 2021 | 160.52M |
March 31, 2021 | 179.05M |
December 31, 2020 | 167.45M |
September 30, 2020 | 112.14M |
June 30, 2020 | 103.24M |
March 31, 2020 | 255.00M |
December 31, 2019 | 255.43M |
September 30, 2019 | 356.42M |
June 30, 2019 | 352.51M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
96.54M
Minimum
Mar 2023
356.42M
Maximum
Sep 2019
190.76M
Average
167.45M
Median
Dec 2020
Gross Profit (TTM) Benchmarks
Annovis Bio Inc | -- |
Emergent BioSolutions Inc | 316.20M |
Vertex Pharmaceuticals Inc | 8.607B |
Geron Corp | -- |
Regeneron Pharmaceuticals Inc | 11.31B |